Sofinnova Investments, Inc. Cin Cor Pharma, Inc. Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$10.75 - $29.84 $64,500 - $179,040	-6,000 Reduced 0.1%	6,073,949 $74.6 Million
Q3 2022 Nov 08, 2022	BUY	$19.9 - $38.94 $10.1 Million - $19.7 Million	506,000 Added 9.08%	6,079,949 $200 Million
Q1 2022 May 16, 2022	BUY	$14.13 - $28.49 $78.8 Million - $159 Million	5,573,949 New	5,573,949 $97.8 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.